-
EU business leaders say AI Act needs to be postponed
Open letter undersigned by leaders of banks, manufacturers and AI companies calls for a delay and a simplification of the incoming AI regulatory regime.
-
EC consults on high-risk AI systems in life sciences and healthcare
Many life sciences and healthcare companies develop or deploy AI-based medical devices and digital health solutions that may fall within the high-risk category.
-
How HR teams can play a key part in the roll out of AI
Key areas where HR teams can add value and contribute to a successful role out of new AI technology within an organization.
-
What’s new with artificial intelligence regulation in Canada and abroad?
Examination of the differing approaches to AI regulation across Canada, the US and Europe and how jurisdictions are shifting their regulatory policies.
-
Navigating the AI frontier: A look at regulation in Canada
A look at the current status of AI regulation in Canada, with comment from Pat Poitevin on compliance challenges and what to expect next.
-
Meeting the challenge of agentic AI and the EU AI Act
Agentic AI systems are designed to act autonomously, sense their environment, make decisions, and take actions without constant human oversight.
-
Legal issues on red teaming in AI
Red teaming is used by organizations to test the flaws and vulnerabilities present within the GenAI models, and the datasets used.
-
Podcast: Matt Worsfold on global AI, the EU AI Act, and the FCA AI sprint
Matt is a partner in Ashurst’s Risk practice. He supports clients’ data governance, and helps manage risk and regulatory compliance.